Phuong N. Huynh

Array ( [id] => 256208 [patent_doc_number] => 07575881 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-08-18 [patent_title] => 'Modulation of nitric oxide signaling through signaling through specific regulation by arginylation and the N-end rule pathway' [patent_app_type] => utility [patent_app_number] => 11/228157 [patent_app_country] => US [patent_app_date] => 2005-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 30882 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 178 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/575/07575881.pdf [firstpage_image] =>[orig_patent_app_number] => 11228157 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5793523 [patent_doc_number] => 20060014204 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-19 [patent_title] => 'Methods of inducing formation of functional and organized lymphatic vessels' [patent_app_type] => utility [patent_app_number] => 11/227816 [patent_app_country] => US [patent_app_date] => 2005-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5893 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20060014204.pdf [firstpage_image] =>[orig_patent_app_number] => 11227816 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5894406 [patent_doc_number] => 20060002945 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-05 [patent_title] => 'Non-anaphylactogenic IgE fusion proteins' [patent_app_type] => utility [patent_app_number] => 11/221203 [patent_app_country] => US [patent_app_date] => 2005-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 18170 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20060002945.pdf [firstpage_image] =>[orig_patent_app_number] => 11221203 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8445811 [patent_doc_number] => 08287860 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-16 [patent_title] => 'Immunogen and antivenom against violin spider venom' [patent_app_type] => utility [patent_app_number] => 11/574488 [patent_app_country] => US [patent_app_date] => 2005-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 16531 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11574488 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5710021 [patent_doc_number] => 20060051366 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-09 [patent_title] => 'Use of soluble CD26 as inhibitor of angiogenesis and inflammation' [patent_app_type] => utility [patent_app_number] => 11/208288 [patent_app_country] => US [patent_app_date] => 2005-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 13680 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0051/20060051366.pdf [firstpage_image] =>[orig_patent_app_number] => 11208288 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4845484 [patent_doc_number] => 20080181892 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-31 [patent_title] => 'Binding Domain Fusion Protein' [patent_app_type] => utility [patent_app_number] => 11/659904 [patent_app_country] => US [patent_app_date] => 2005-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 68888 [patent_no_of_claims] => 108 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20080181892.pdf [firstpage_image] =>[orig_patent_app_number] => 11659904 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5776347 [patent_doc_number] => 20060104987 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-18 [patent_title] => 'Novel nucleic acid molecules correlated with the rhesus weak D phenotype' [patent_app_type] => utility [patent_app_number] => 11/200624 [patent_app_country] => US [patent_app_date] => 2005-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 15508 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20060104987.pdf [firstpage_image] =>[orig_patent_app_number] => 11200624 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5590452 [patent_doc_number] => 20060039903 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-23 [patent_title] => 'Immunomodulation and effect on cell processes relating to serotonin family receptors' [patent_app_type] => utility [patent_app_number] => 11/197673 [patent_app_country] => US [patent_app_date] => 2005-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 44691 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20060039903.pdf [firstpage_image] =>[orig_patent_app_number] => 11197673 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5514219 [patent_doc_number] => 20090214525 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'Novel anti-igf-ir antibodies and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/658739 [patent_app_country] => US [patent_app_date] => 2005-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13414 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20090214525.pdf [firstpage_image] =>[orig_patent_app_number] => 11658739 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4938409 [patent_doc_number] => 20080075728 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-27 [patent_title] => 'Combination Therapies Of Hmgb And Complement Inhibitors Against Inflammation' [patent_app_type] => utility [patent_app_number] => 11/632257 [patent_app_country] => US [patent_app_date] => 2005-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 19093 [patent_no_of_claims] => 102 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20080075728.pdf [firstpage_image] =>[orig_patent_app_number] => 11632257 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5769507 [patent_doc_number] => 20050266009 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-01 [patent_title] => 'Antibodies and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/166740 [patent_app_country] => US [patent_app_date] => 2005-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 31267 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20050266009.pdf [firstpage_image] =>[orig_patent_app_number] => 11166740 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5655154 [patent_doc_number] => 20060140889 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-29 [patent_title] => 'Affinity proteins for controlled application of cosmetic substances' [patent_app_type] => utility [patent_app_number] => 11/150871 [patent_app_country] => US [patent_app_date] => 2005-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 56936 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0140/20060140889.pdf [firstpage_image] =>[orig_patent_app_number] => 11150871 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6925368 [patent_doc_number] => 20050238623 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-27 [patent_title] => 'Method for treating mammals with modified mammalian blood' [patent_app_type] => utility [patent_app_number] => 11/150084 [patent_app_country] => US [patent_app_date] => 2005-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7319 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0238/20050238623.pdf [firstpage_image] =>[orig_patent_app_number] => 11150084 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4886425 [patent_doc_number] => 20080260757 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-23 [patent_title] => 'Bispecific Fusion Antibodies With Enhanced Serum Half-Life' [patent_app_type] => utility [patent_app_number] => 11/628149 [patent_app_country] => US [patent_app_date] => 2005-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 34831 [patent_no_of_claims] => 74 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20080260757.pdf [firstpage_image] =>[orig_patent_app_number] => 11628149 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5766811 [patent_doc_number] => 20060018912 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-26 [patent_title] => 'Snares for pathogenic or infectious agents and uses related thereto' [patent_app_type] => utility [patent_app_number] => 11/139272 [patent_app_country] => US [patent_app_date] => 2005-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 13828 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20060018912.pdf [firstpage_image] =>[orig_patent_app_number] => 11139272 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5793130 [patent_doc_number] => 20060013811 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-19 [patent_title] => 'Methods of treating IgE-associated disorders and compositions for use therein' [patent_app_type] => utility [patent_app_number] => 11/132163 [patent_app_country] => US [patent_app_date] => 2005-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11208 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0013/20060013811.pdf [firstpage_image] =>[orig_patent_app_number] => 11132163 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5520869 [patent_doc_number] => 20090028850 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-29 [patent_title] => 'Prolongation of survival of an allograft by inhibiting complement activity' [patent_app_type] => utility [patent_app_number] => 11/596382 [patent_app_country] => US [patent_app_date] => 2005-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 17942 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20090028850.pdf [firstpage_image] =>[orig_patent_app_number] => 11596382 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5166093 [patent_doc_number] => 20070287680 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-13 [patent_title] => 'Combined Active and Passive Targeting of Biologically Active Agents' [patent_app_type] => utility [patent_app_number] => 11/547872 [patent_app_country] => US [patent_app_date] => 2005-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 8050 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20070287680.pdf [firstpage_image] =>[orig_patent_app_number] => 11547872 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5391105 [patent_doc_number] => 20090208418 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-20 [patent_title] => 'SUPERANTIBODY SYNTHESIS AND USE IN DETECTION, PREVENTION AND TREATMENT OF DISEASE' [patent_app_type] => utility [patent_app_number] => 11/912992 [patent_app_country] => US [patent_app_date] => 2005-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 16729 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20090208418.pdf [firstpage_image] =>[orig_patent_app_number] => 11912992 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5769480 [patent_doc_number] => 20050265995 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-01 [patent_title] => 'Tissue targeted complement modulators' [patent_app_type] => utility [patent_app_number] => 11/116939 [patent_app_country] => US [patent_app_date] => 2005-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 29709 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0265/20050265995.pdf [firstpage_image] =>[orig_patent_app_number] => 11116939 [rel_patent_id] =>[rel_patent_doc_number] =>)